As of August 13, 2026, the CDC has confirmed 2,566 measles cases in the United States for the year, already exceeding the full 2025 total of 2,289 amid 38 ongoing or new outbreaks, with 94% of cases outbreak-associated and concentrated in under-vaccinated communities. Primary drivers include sustained transmission from imported cases in populations with suboptimal MMR coverage, measles' high basic reproduction number, and clustering in specific states like Texas, Pennsylvania, and South Carolina. Recent weekly increments of roughly 90–100 cases reflect continued spread, while the CDC's weekly surveillance updates and an upcoming PAHO-linked review of elimination status could influence reporting and trader assessments of final August 31 totals.
Resumen experimental generado por IA con datos de Polymarket. Esto no es asesoramiento de trading y no influye en cómo se resuelve este mercado. · Actualizado¿Casos de sarampión en EE. UU. antes del 31 de agosto?
¿Casos de sarampión en EE. UU. antes del 31 de agosto?
$18,617 Vol.
31 ago 2026
2750+
75%
2600+
99%
2650+
96%
2700+
93%
$18,617 Vol.
2750+
$2,229 Vol.
75%
2600+
$3,985 Vol.
99%
2650+
$1,818 Vol.
96%
2700+
$1,134 Vol.
93%
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by August 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.As of August 13, 2026, the CDC has confirmed 2,566 measles cases in the United States for the year, already exceeding the full 2025 total of 2,289 amid 38 ongoing or new outbreaks, with 94% of cases outbreak-associated and concentrated in under-vaccinated communities. Primary drivers include sustained transmission from imported cases in populations with suboptimal MMR coverage, measles' high basic reproduction number, and clustering in specific states like Texas, Pennsylvania, and South Carolina. Recent weekly increments of roughly 90–100 cases reflect continued spread, while the CDC's weekly surveillance updates and an upcoming PAHO-linked review of elimination status could influence reporting and trader assessments of final August 31 totals.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by August 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Mercado abierto: Jul 31, 2026, 10:25 AM ET
Volumen
$18,617Fecha de finalización
31 ago 2026Mercado abierto
Jul 31, 2026, 10:25 AM ETResolver
0x65070BE91...Resultado propuesto: Sí
Sin disputa
Resultado final: Sí
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by August 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.As of August 13, 2026, the CDC has confirmed 2,566 measles cases in the United States for the year, already exceeding the full 2025 total of 2,289 amid 38 ongoing or new outbreaks, with 94% of cases outbreak-associated and concentrated in under-vaccinated communities. Primary drivers include sustained transmission from imported cases in populations with suboptimal MMR coverage, measles' high basic reproduction number, and clustering in specific states like Texas, Pennsylvania, and South Carolina. Recent weekly increments of roughly 90–100 cases reflect continued spread, while the CDC's weekly surveillance updates and an upcoming PAHO-linked review of elimination status could influence reporting and trader assessments of final August 31 totals.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by August 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Volumen
$18,617Fecha de finalización
31 ago 2026Mercado abierto
Jul 31, 2026, 10:25 AM ETResolver
0x65070BE91...Resultado propuesto: Sí
Sin disputa
Resultado final: Sí
As of August 13, 2026, the CDC has confirmed 2,566 measles cases in the United States for the year, already exceeding the full 2025 total of 2,289 amid 38 ongoing or new outbreaks, with 94% of cases outbreak-associated and concentrated in under-vaccinated communities. Primary drivers include sustained transmission from imported cases in populations with suboptimal MMR coverage, measles' high basic reproduction number, and clustering in specific states like Texas, Pennsylvania, and South Carolina. Recent weekly increments of roughly 90–100 cases reflect continued spread, while the CDC's weekly surveillance updates and an upcoming PAHO-linked review of elimination status could influence reporting and trader assessments of final August 31 totals.
Resumen experimental generado por IA con datos de Polymarket. Esto no es asesoramiento de trading y no influye en cómo se resuelve este mercado. · Actualizado
Cuidado con los enlaces externos.
Cuidado con los enlaces externos.
Preguntas frecuentes